Closed System Transfer Devices for Drug Preparation
April 2011 : State of Pharmacy Compounding - Vol. 8 No. 4 - Page #14
Download   Digital Edition   Print   Share

Recognizing the safety risks in hazardous drug transfer, 44% of facilities have incorporated closed system transfer devices (CSTDs) into the compounding process. Those who have not adopted CSTDs cited budget constraints as the most common reason for not doing so. 

For more information on closed system transfer devices, visit and click on Closed System Transfer Devices.

To view the PDF, click the download link above.

Current Issue

Our mission is to provide health system pharmacists with information to streamline pharmacy operations and promote patient safety.

As a requester to PP&P you will receive all monthly issues, as well as our annual Resource Guide of product and service providers and all of our timely supplements on pharmacy's hot-button issues.

Thank you for reading PP&P, and we look forward to providing you with information to enhance the field of pharmacy.